Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer

M.D. Anderson Cancer Center

Status: Completed

Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Recurrent Malignant Solid Neoplasm; Metastatic Malignant Solid Neoplasm; Recurrent Hematologic Malignancy; Advanced Malignant Solid Neoplasm; Locally Advanced Malignant Solid Neoplasm; COVID-19 Infection

Treatments: Other: Survey Administration

Study type: Observational

Funder types: Other

Identifiers

NCT05058339

2020-1196 (Other Identifier)

NCI-2021-09080 (Registry Identifier)

Details and patient eligibility

About

This study assesses the level of distress felt by cancer patients due to the coronavirus disease 2019 (COVID-19) pandemic. Researchers also want to learn if patients prefer to receive supportive care (palliative care) in person or through telemedicine (visits by phone or video call, such as Zoom). Information from this study may help doctors better understand how COVID-19 has affected patients with advanced cancer, patients' perceptions of telehealth, and may help clinicians tailor care to patients' needs during the pandemic.

Full description

PRIMARY OBJECTIVES:

I. Assess advanced cancer patients' level of distress due to the COVID-19 pandemic.

II. Assess patients' overall preference towards palliative telemedicine vs in person visits during the COVID-19 pandemic.

SECONDARY OBJECTIVES:

I. Assess associations between patient characteristics and perceptions of overall distress due to the COVID-19 pandemic.

II. Assess associations between patient characteristics and their attitudes and beliefs towards palliative telemedicine during the COVID-19 pandemic.

III. Compare the attitudes and beliefs towards palliative telemedicine between patients who completed visits via video vs telephone.

OUTLINE:

Patients complete survey over 20 minutes.

Enrollment: 223 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of advanced cancer, defined as locally advanced, recurrent or metastatic disease
• Age 18 or greater
• Patient presenting for at least two follow-up visits with Supportive Care visit since the COVID19 pandemic (after March 23, 2020), consisting of either in-person, or virtual
• For patients who have had two consecutive video visits, or consecutive telephone visits with supportive care, they will be asked to complete additional questions regarding telehealth visits

Exclusion criteria

• Memorial Delirium Assessment Scale (MDAS) of 7 or more or if determined to be of impaired cognition by the clinician at the time of clinic visit as documented in the visit either by history or exam. Providers routinely note screening for mental status with routine administration of the MDAS or history of altered cognition or noted on exam
• Non-English-speaking participants
• Unwilling or unable to provide informed consent

Trial design

223 participants in 1 patient group

Observational (survey)

Description:

Patients complete survey over 20 minutes.

Treatment:

Other: Survey Administration